A multi-country non-inferiority cluster randomized trial of frontloaded smear microscopy for the diagnosis of pulmonary tuberculosis
- PMID: 21765808
- PMCID: PMC3134460
- DOI: 10.1371/journal.pmed.1000443
A multi-country non-inferiority cluster randomized trial of frontloaded smear microscopy for the diagnosis of pulmonary tuberculosis
Abstract
Background: More than 50 million people around the world are investigated for tuberculosis using sputum smear microscopy annually. This process requires repeated visits and patients often drop out.
Methods and findings: This clinical trial of adults with cough ≥2 wk duration (in Ethiopia, Nepal, Nigeria, and Yemen) compared the sensitivity/specificity of two sputum samples collected "on the spot" during the first visit plus one sputum sample collected the following morning (spot-spot-morning [SSM]) versus the standard spot-morning-spot (SMS) scheme. Analyses were per protocol analysis (PPA) and intention to treat (ITT). A sub-analysis compared just the first two smears of each scheme, spot-spot and spot-morning. In total, 6,627 patients (3,052 SSM/3,575 SMS) were enrolled; 6,466 had culture and 1,526 were culture-positive. The sensitivity of SSM (ITT, 70.2%, 95% CI 66.5%-73.9%) was non-inferior to the sensitivity of SMS (PPA, 65.9%, 95% CI 62.3%-69.5%). Similarly, the specificity of SSM (ITT, 96.9%, 95% CI 93.2%-99.9%) was non-inferior to the specificity of SMS (ITT, 97.6%, 95% CI 94.0%-99.9%). The sensitivity of spot-spot (ITT, 63.6%, 95% CI 59.7%-67.5%) was also non-inferior to spot-morning (ITT, 64.8%, 95% CI 61.3%-68.3%), as the difference was within the selected -5% non-inferiority limit (difference ITT = 1.4%, 95% CI -3.7% to 6.6%). Patients screened using the SSM scheme were more likely to provide the first two specimens than patients screened with the SMS scheme (98% versus 94.2%, p<0.01). The PPA and ITT analysis resulted in similar results.
Conclusions: The sensitivity and specificity of SSM are non-inferior to those of SMS, with a higher proportion of patients submitting specimens. The scheme identifies most smear-positive patients on the first day of consultation.
Trial registration: Current Controlled Trials ISRCTN53339491. Please see later in the article for the Editors' Summary.
Conflict of interest statement
AR is employed by WHO/TDR the organization which administered the USAID and BMGF grants that funded the study. AR is Secretary of the New Diagnostics Working Group, Stop TB Partnership.
Figures
Comment in
-
Two sputum samples at once for diagnosis of tuberculosis in Africa has equivalent sensitivity and specificity to the standard initial sample followed by a morning sample strategy.Evid Based Med. 2011 Dec;16(6):173-4. doi: 10.1136/ebm.2011.100197. Epub 2011 Sep 26. Evid Based Med. 2011. PMID: 21949262 No abstract available.
References
-
- World Health Organization. Geneva: World Health Organization; 2009. Global tuberculosis control: epidemiology, strategy, financing.
-
- Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis. 2007;196(Suppl 1):S15–S27. - PubMed
-
- International Union Against Tuberculosis and Lung Disease. Sputum examination for tuberculosis by direct microscopy in low-income countries. Paris: International Union Against Tuberculosis and Lung Disease; 2000. Technical guide. 5th edition.
-
- World Health Organization. Geneva: World Health Organization; 1998. Tuberculosis handbook.
-
- Andrews RH, Radhakrishna S. A comparison of two methods of sputum collection in the diagnosis of pulmonary tuberculosis. Tubercle. 1959;40:155–162. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
